Tuesday, February 12, 2008
12:00 - 3:00 pm

Kuleto's Trattoria
1095 Rollins Road
Burlingame, CA 94010
Global regulations and market forces are increasing the complexity of drug safety while compressing the timelines for compliance. Biopharmaceutical companies are considering their safety data strategy early in the development cycle.

Join Sentrx as we discuss the market demands on small and medium enterprises, safety data strategies to help meet the demands, and the decision process of a San Francisco-based biopharmaceutical company that confronted the demands.